PATENT CLAIM ANALYSIS

Application Number: 15860781
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["544", "331000"]

Abstract:
Provided herein are compounds of the General Formula I: and stereoisomers and pharmaceutically acceptable salts or solvates thereof, in which A, B, D, E, X 1 , X 2 , X 3  and X 4  have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including diseases or disorders mediated by a RET kinase.

Claim (Index 18):
The method of  claim 1 , wherein the compound of Formula I is or a pharmaceutically acceptable salt or solvate thereof.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 86.0
- Lexical Diversity: 1.63462
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15860849', '15858658', '15860852', '15860808', '15860894']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8470871988323242
- 35 USC 102 Novelty (BERT): 0.6371332144614432
- Combined Prediction Score: 0.8260918003952361
- Mean Citation Score: 555.9032100000002
- Max Citation Score: 590.9769
- Similarity Product: 573.9709194049001

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test